Autoimmune hearing loss in chronic inflammatory demyelinating polyneuropathy.
Sivakumar
K
K
Barrow Neurological Institute, University of Arizona College of Medicine, Phoenix, AZ, USA. ksivakumar@azneuromuscular.org
Fife
Terry D
TD
D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001323:Autoantibodies / Q000276:immunology; D003051:Cochlea / Q000276:immunology* / Q000503:physiopathology; D005260:Female; D006198:Hair Cells, Auditory / Q000276:immunology / Q000503:physiopathology; D006319:Hearing Loss, Sensorineural / Q000175:diagnosis / Q000276:immunology* / Q000503:physiopathology; D006801:Humans; D018908:Muscle Weakness / Q000276:immunology / Q000503:physiopathology; D009419:Nerve Tissue Proteins / Q000276:immunology; D010525:Peripheral Nerves / Q000276:immunology / Q000503:physiopathology; D020277:Polyradiculoneuropathy, Chronic Inflammatory Demyelinating / Q000150:complications* / Q000276:immunology / Q000503:physiopathology; D011241:Prednisone / Q000627:therapeutic use; D016896:Treatment Outcome; D014717:Vertigo / Q000276:immunology / Q000503:physiopathology; D014722:Vestibule, Labyrinth / Q000276:immunology* / Q000503:physiopathology
D000893:Anti-Inflammatory Agents; D001323:Autoantibodies; D009419:Nerve Tissue Proteins; D011241:Prednisone